Advanced Epithelial Ovarian Cancer: Radspherin® Treatment

We are studying whether Radspherin® can improve survival and quality of life for patients with advanced ovarian cancer and peritoneal metastasis. This trial focuses on those scheduled for chemotherapy and surgery.

>2 years≤5 visitsEfficacy phase (II)Cost ReimbursementPartially RemoteStandard MedicinesInjectionGynecology and ObstetricsOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Radermin

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Calcium Carbonate
Calcium carbonate is a substance used to provide calcium for bone health and to neutralize excess stomach acid.
Etofenamate
Etofenamate is a topical anti-inflammatory substance that relieves pain and swelling in muscles and joints.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Activon
Activon Extra
Cartidol

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
UZ Leuven
Gynaecological Oricology
Heverlee, Belgium
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Unità Operativa Complessa di Ginecologia Oncologica e Carcinoma Ovarico
La Massimina-Casal Lumbroso, Italy
Oslo University Hospital HF
Department of Gynaecological cancer
Oslo, Norway
Sponsor: Oncoinvent AS
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.